Stock listing
ASX:PAB Patrys Limited Share Price
Home listing (ASX) of Patrys Limited
Follow Patrys Limited into a list and get an email when it puts out news.
Share price · ASX:PAB
$0.022 AUD -0.001 (-4.3%)
Close on Nov 20, 2026
- Day range
- $0.022 – $0.022 AUDNov 20, 2026
- Volume
- 207 sharesNov 20, 2026
- Market cap
- $7.50M AUDAt the close on Nov 20, 2026 · price × 340.7M shares outstanding
- 52-week range
- $0.020 – $0.052 AUDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $9,892 AUDMedian day 123,867 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ASX:PAB · Home | $0.022 AUD | -0.001 (-4.3%) | 207 | $0.022 | $0.022 | $0.022 | $0.023 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ASX:PAB · AUD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.022 | -0.001 | -4.3% | $0.022 | $0.022 | $0.022 | 207 | |
| $0.023 | 0.000 | 0.0% | $0.023 | $0.023 | $0.023 | 102,990 | |
| $0.023 | 0.000 | 0.0% | $0.023 | $0.023 | $0.023 | 67,179 | |
| $0.023 | 0.000 | 0.0% | $0.023 | $0.023 | $0.023 | 9,493 | |
| $0.023 | 0.000 | 0.0% | $0.024 | $0.024 | $0.023 | 239,300 | |
| $0.023 | 0.000 | 0.0% | $0.022 | $0.023 | $0.022 | 96,017 | |
| $0.023 | -0.001 | -4.2% | $0.022 | $0.023 | $0.022 | 46,321 | |
| $0.024 | +0.004 | +20.0% | $0.020 | $0.024 | $0.020 | 353,610 | |
| $0.020 | -0.002 | -9.1% | $0.021 | $0.021 | $0.020 | 1,081,082 | |
| $0.022 | 0.000 | 0.0% | $0.022 | $0.022 | $0.022 | 0 | |
| $0.022 | -0.001 | -4.3% | $0.023 | $0.023 | $0.020 | 370,603 | |
| $0.023 | -0.002 | -8.0% | $0.025 | $0.025 | $0.023 | 64,169 | |
| $0.025 | 0.000 | 0.0% | $0.025 | $0.025 | $0.025 | 400 | |
| $0.025 | +0.001 | +4.2% | $0.025 | $0.025 | $0.025 | 5,052 | |
| $0.024 | -0.001 | -4.0% | $0.024 | $0.024 | $0.024 | 1,707 | |
| $0.025 | 0.000 | 0.0% | $0.026 | $0.026 | $0.025 | 327,462 | |
| $0.025 | -0.001 | -3.8% | $0.026 | $0.026 | $0.025 | 644,150 | |
| $0.026 | -0.001 | -3.7% | $0.027 | $0.027 | $0.026 | 36,610 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 156,199 | |
| $0.027 | -0.001 | -3.6% | $0.028 | $0.029 | $0.027 | 574,454 | |
| $0.028 | 0.000 | 0.0% | $0.028 | $0.028 | $0.028 | 7,385 | |
| $0.028 | +0.001 | +3.7% | $0.029 | $0.029 | $0.028 | 62,965 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 108,508 | |
| $0.027 | 0.000 | 0.0% | $0.027 | $0.027 | $0.027 | 0 | |
| $0.027 | -0.002 | -6.9% | $0.028 | $0.028 | $0.027 | 553,613 | |
| $0.029 | -0.001 | -3.3% | $0.029 | $0.029 | $0.029 | 34,714 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 16,667 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 137,470 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.031 | $0.030 | 1,394,568 | |
| $0.030 | -0.002 | -6.3% | $0.031 | $0.031 | $0.030 | 990,343 | |
| $0.032 | +0.002 | +6.7% | $0.031 | $0.032 | $0.030 | 69,472 | |
| $0.030 | -0.001 | -3.2% | $0.030 | $0.030 | $0.030 | 1,567,603 | |
| $0.031 | +0.001 | +3.3% | $0.031 | $0.031 | $0.031 | 21,770 | |
| $0.030 | -0.002 | -6.3% | $0.032 | $0.032 | $0.030 | 290,811 | |
| $0.032 | -0.001 | -3.0% | $0.032 | $0.032 | $0.032 | 10,000 | |
| $0.033 | +0.002 | +6.5% | $0.033 | $0.033 | $0.033 | 141,874 | |
| $0.031 | -0.002 | -6.1% | $0.030 | $0.032 | $0.030 | 110,373 | |
| $0.033 | +0.003 | +10.0% | $0.030 | $0.033 | $0.030 | 154,596 | |
| $0.030 | -0.001 | -3.2% | $0.031 | $0.031 | $0.030 | 517,830 | |
| $0.031 | -0.001 | -3.1% | $0.031 | $0.031 | $0.031 | 10,065 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.032 | 103,846 | |
| $0.032 | -0.001 | -3.0% | $0.033 | $0.034 | $0.032 | 242,965 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 30,299 | |
| $0.033 | -0.001 | -2.9% | $0.033 | $0.033 | $0.033 | 79,599 | |
| $0.034 | 0.000 | 0.0% | $0.034 | $0.034 | $0.034 | 207,276 | |
| $0.034 | 0.000 | 0.0% | $0.033 | $0.034 | $0.033 | 1,181,719 | |
| $0.034 | -0.001 | -2.9% | $0.034 | $0.034 | $0.033 | 535,087 | |
| $0.035 | +0.001 | +2.9% | $0.034 | $0.035 | $0.031 | 2,077,129 | |
| $0.034 | +0.003 | +9.7% | $0.031 | $0.035 | $0.031 | 1,332,686 | |
| $0.031 | -0.001 | -3.1% | $0.031 | $0.032 | $0.031 | 137,360 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.033 | $0.032 | 493,958 | |
| $0.032 | 0.000 | 0.0% | $0.032 | $0.032 | $0.032 | 753,479 | |
| $0.032 | +0.002 | +6.7% | $0.031 | $0.032 | $0.031 | 446,329 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.031 | $0.030 | 620,799 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 969,792 | |
| $0.030 | -0.001 | -3.2% | $0.030 | $0.030 | $0.030 | 582,118 | |
| $0.031 | +0.001 | +3.3% | $0.030 | $0.031 | $0.030 | 17,733 | |
| $0.030 | -0.001 | -3.2% | $0.030 | $0.030 | $0.030 | 102,429 | |
| $0.031 | +0.001 | +3.3% | $0.031 | $0.032 | $0.030 | 597,129 | |
| $0.030 | 0.000 | 0.0% | $0.030 | $0.030 | $0.030 | 0 | |
| $0.030 | -0.001 | -3.2% | $0.031 | $0.031 | $0.030 | 522,879 | |
| $0.031 | -0.001 | -3.1% | $0.032 | $0.032 | $0.031 | 45,058 | |
| $0.032 | -0.001 | -3.0% | $0.033 | $0.033 | $0.032 | 35,294 | |
| $0.033 | 0.000 | 0.0% | $0.033 | $0.033 | $0.033 | 250 | |
| $0.033 | +0.001 | +3.1% | $0.032 | $0.033 | $0.032 | 238,219 |
Splits
2 splits since 2013 · ASX:PAB · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation | |
| 96-for-89 | Split |
- Ticker
- ASX:PAB
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
What changed lately
Latest news release · Nov 11, 2026
Change of Auditor
Latest deck · Oct 13, 2026
Investor Presentation (October 2026)
Investor deck · 17 slides
Latest news
Change of Auditor
Nov 11, 2026
Closed $0.023 (0.0%) on Nov 12, 2026
Change in substantial holding
Nov 9, 2026
Closed $0.024 (+20.0%) on Nov 10, 2026
Change of Director's Interest Notice x2
Nov 9, 2026
Closed $0.024 (+20.0%) on Nov 10, 2026
Cleansing Notice
Nov 9, 2026
Closed $0.024 (+20.0%) on Nov 10, 2026
Application for quotation of securities - PAB
Nov 9, 2026
Closed $0.024 (+20.0%) on Nov 10, 2026
Letter to Shareholders - Annual General Meeting
Oct 29, 2026
Closed $0.024 (-4.0%) on Oct 30, 2026
Notice of Annual General Meeting/Proxy Form
Oct 29, 2026
Closed $0.024 (-4.0%) on Oct 30, 2026
Appendix 4C - Quarterly - 30 September 2026
Oct 28, 2026
Closed $0.025 (0.0%) on Oct 29, 2026
RLS-2202 Phase 1a Trial Advances to Cohort 2
Oct 21, 2026
Closed $0.028 (0.0%) on Oct 22, 2026
Investor Presentation
Oct 12, 2026
Closed $0.03 (0.0%) on Oct 13, 2026
Patrys Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 38 in the last 12 months · 191 in all · newest Nov 11, 2026 · oldest 2016
- Decks
- 46 decks · latest Oct 13, 2026
Where Patrys Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ASX:PAB · Home listing · This page | ASX | Australia | AUD |
| OTC:PABAF | OTC | United States | USD |
Cash and shares
Oct 2026 deck · Patrys — Investor Presentation (October 2026)
- Cash
- $3.36 million
- Shares outstanding
- 674,845,324
Valuation
EV/sales 8.2× against a median of −1.5×: 3rd lowest of 4 Biotechnology companies shown. Statements: Year to Jun 30, 2025 · price Nov 20, 2026
- Enterprise value
- $6.75M AUD
- P/E
- Loss
- EV/sales
- 8.2×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 10.2×
- Gross margin
- 100.0%
- Operating margin
- −327.0%
- Net margin
- −363.7%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Patrys Limited · ASX:PAB | US$4.96M | US$4.47M | n/a | 8.2× | n/a | 10.2× | −363.7% | 0.0× | n/a |
| CNS Pharmaceuticals, Inc. · NASDAQ:CNSP | US$5.25M | −US$11.96M | n/a | n/a | n/a | 0.3× | n/a | 0.0× | 0.74 |
| Soligenix, Inc. · NASDAQ:SNGX | US$5.14M | −US$3.61M | n/a | n/a | n/a | 0.8× | n/a | 0.0× | 1.76 |
| Rakovina Therapeutics Inc · TSXV:RKV | US$5.10M | US$7.20M | n/a | n/a | n/a | n/a | n/a | n/a | -0.43 |
| StimCell Energetics Inc. · OTC:STME | US$5.10M | US$5.09M | n/a | n/a | n/a | n/a | n/a | n/a | 0.99 |
| Longeveron Inc. · NASDAQ:LGVN | US$5.05M | −US$1.78M | n/a | −1.5× | n/a | 1.1× | n/a | 0.1× | 1.55 |
| Oncodesign Precision Medicine S.A. · EURONEXT:ALOPM | US$5.04M | US$8.61M | 0.8× | 30.0× | 0.9× | 1.2× | n/a | 1.6× | n/a |
| Invex Therapeutics Ltd. · ASX:IXC | US$4.86M | US$2.20M | n/a | n/a | n/a | 1.9× | n/a | 0.0× | n/a |
| Can-Fite BioPharma Ltd. · TASE:CANF | US$4.86M | −US$2.14M | n/a | −5.3× | n/a | 1.0× | n/a | 0.0× | n/a |
| Zenith Capital Corporation · OTC:ZHCLF | US$4.83M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.06 |
| NFL Biosciences SA · EURONEXT:ALNFL | US$4.71M | US$5.36M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Median of the others | US$5.05M | US$2.20M | 0.8× | −1.5× | 0.9× | 1.0× | 0.0× | 0.87 |
Team and board
Officers
| Officer | Role |
|---|---|
| Samantha South | Chief Executive Officer |
Board
| Director | Role |
|---|---|
| Peter Christie | Non-Executive Chairman |
| Anton Uvarov | Non-Executive Director |
| Brian Leedman | Non-Executive Director |
| Dino Cercarelli | Non-Executive Director |
| Leanne Kite | Non-Executive Director |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q4 2025 | Sep 5, 2025 | +50.0% |
| Q2 2025 | Feb 21, 2025 | +17.9% |
| Q2 2023 | Feb 24, 2023 · Before open | 0.0% |
| Q4 2022 | Aug 30, 2022 · After close | +3.8% |
| Q2 2022 | Feb 24, 2022 | 0.0% |
| Q4 2021 | Aug 25, 2021 | +22.1% |
| Q2 2021 | Feb 19, 2021 | 0.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2026) | Investor deck | 17 slides | Oct 13, 2026 |
| Investor Presentation (July 2026) | Investor deck | 19 slides | Jul 27, 2026 |
| Investor Presentation (March 2026) | Investor deck | 14 slides | Mar 31, 2026 |
| Investor Presentation (January 2026) | Investor deck | 21 slides | Jan 28, 2026 |
| Shareholder Meeting (November 2024) | Shareholder meeting | 18 slides | Nov 22, 2024 |
| Investor Presentation (November 2023) | Investor deck | 26 slides | Nov 20, 2023 |
| Shareholder Meeting (November 2023) | Shareholder meeting | 24 slides | Nov 15, 2023 |
| Investor Presentation (January 2023) | Investor deck | 27 slides | Jan 25, 2023 |
| Investor Presentation (November 2022) | Investor deck | 27 slides | Nov 24, 2022 |
| ShareCafe Small Cap "Hidden Gems" Webinar (November 2022) | Conference | 19 slides | Nov 24, 2022 |
All 46 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Shareholder Meeting (November 2022) | Shareholder meeting | 25 slides | Nov 16, 2022 |
| Investor Presentation (September 2022) | Investor deck | 25 slides | Sep 1, 2022 |
| Shareholder Meeting (November 2021) | Shareholder meeting | 23 slides | Nov 5, 2021 |
| Investor Presentation (November 2021) | Investor deck | 25 slides | November 2021 |
| Investor Presentation (November 2021) | Investor deck | 33 slides | Nov 1, 2021 |
| Investor Presentation (September 2021) | Investor deck | 21 slides | Sep 28, 2021 |
| Investor Presentation (May 2021) | Investor deck | 25 slides | May 2021 |
| Shareholder Meeting (November 2020) | Shareholder meeting | 19 slides | Nov 19, 2020 |
| Investor Presentation (November 2020) | Investor deck | 33 slides | Nov 5, 2020 |
| Investor Presentation (June 2020) | Investor deck | 35 slides | Jun 18, 2020 |
| Shareholder Meeting (November 2019) | Shareholder meeting | 22 slides | Nov 21, 2019 |
| Investor Presentation (July 2019) | Investor deck | 27 slides | Jul 24, 2019 |
| Shareholder Meeting (November 2018) | Shareholder meeting | 26 slides | Nov 22, 2018 |
| Shareholder Meeting (November 2017) | Shareholder meeting | 26 slides | Nov 23, 2017 |
| Shareholder Meeting (November 2016) | Shareholder meeting | 18 slides | Nov 24, 2016 |
| Shareholder Meeting (November 2015) | Shareholder meeting | 12 slides | Nov 11, 2015 |
| Shareholder Meeting (November 2014) | Shareholder meeting | 11 slides | Nov 12, 2014 |
| Investor Presentation (September 2014) | Investor deck | 24 slides | Sep 18, 2014 |
| Shareholder Meeting (October 2013) | Shareholder meeting | 22 slides | Oct 23, 2013 |
| Investor Presentation (November 2012) | Investor deck | 29 slides | Nov 27, 2012 |
| Shareholder Meeting (October 2012) | Shareholder meeting | 20 slides | Oct 31, 2012 |
| Non-Deal Roadshow (April 2012) | Roadshow | 47 slides | Apr 12, 2012 |
| Shareholder Meeting (November 2011) | Shareholder meeting | 15 slides | Nov 30, 2011 |
| Investor Presentation (October 2011) | Investor deck | 20 slides | Oct 10, 2011 |
| Investor Presentation (June 2011) | Investor deck | 19 slides | Jun 2, 2011 |
| Investor Presentation (March 2011) | Investor deck | 26 slides | Mar 9, 2011 |
| Shareholder Meeting (October 2010) | Shareholder meeting | 18 slides | Oct 29, 2010 |
| Investor Presentation (October 2010) | Investor deck | 18 slides | Oct 15, 2010 |
| Shareholder Meeting (November 2009) | Shareholder meeting | 16 slides | Nov 27, 2009 |
| AusBiotech Life Sciences Investment Summit 2009 | Conference | 7 slides | Oct 27, 2009 |
| Investor Presentation (September 2009) | Investor deck | 25 slides | Sep 22, 2009 |
| Corporate Update (July 2009) | Corporate update | 14 slides | Jul 1, 2009 |
| Shareholder Meeting (November 2008) | Shareholder meeting | 29 slides | Nov 27, 2008 |
| 6th Annual Australian Biotechnology Summit (July 2008) | Conference | 23 slides | Jul 31, 2008 |
| Excellence in Biotechnology 2008 | Conference | 19 slides | Apr 21, 2008 |
| Lodge Mid Cap Confab 2008 | Conference | 18 slides | Apr 9, 2008 |
Financings
| Raise | Date | In US dollars |
|---|---|---|
| Private placement of fully paid ordinary shares Announced: about A$3.2M · A$0.024 a share · Warrants at A$0.048 · Templar Corporate Pty Ltd Dealers: Templar Corporate Pty Ltd (lead) Insiders: Directors intend to participate to raise an additional A$160,000, subject to shareholder approval Use of proceeds: Phase 1A clinical trial, drug manufacturing, pre-IND FDA preparation, intellectual property and working capital | Apr 20, 2026 | US$2.29M |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in AUD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 828.5K | 1.39M | 2.85M | 27.5K | 27.5K | 27.5K | 844.4K | 520.5K | 53.3K | 275.0K |
| Cost of revenue | 47.0K | 47.0K | -3.31M | -1.31M | -745.3K | 0 | -478.5K | -592.7K | ||
| Gross profit | 828.5K | 1.39M | 2.80M | 3.33M | 1.34M | 772.8K | 844.4K | 520.5K | 531.7K | 867.7K |
| Research and development | 1.75M | 3.07M | 7.52M | 8.09M | 2.86M | 1.37M | 1.69M | 1.31M | 1.27M | 1.04M |
| Selling, general and administrative | 1.78M | 1.86M | 2.39M | 2.03M | 2.54M | 2.15M | 2.57M | 1.71M | 1.13M | 954.8K |
| Operating income | -2.71M | -3.54M | -9.86M | -11.4M | -5.86M | -3.49M | -3.41M | -2.50M | -2.36M | -1.72M |
| Depreciation and amortization | 49.3K | 47.0K | 47.0K | 47.5K | 48.6K | 47.8K | 48.3K | 47.8K | 47.5K | 20.1K |
| EBITDA | -2.66M | -3.49M | -9.81M | -11.3M | -5.81M | -3.45M | -3.36M | -2.45M | -2.31M | -1.70M |
| Interest expense | 8.10K | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Income before tax | -3.01M | -4.82M | -9.84M | -11.6M | -5.74M | -3.37M | -411.3K | -2.50M | -1.47M | -1.58M |
| Income tax | -807.3K | -1.29M | -2.78M | -4.79M | -1.67M | -623.2K | -644.3K | -455.2K | -410.2K | -502.5K |
| Net income | -3.01M | -3.54M | -7.06M | -6.78M | -4.06M | -2.75M | -411.3K | -2.50M | -1.06M | -1.08M |
| Earnings per share, basic | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 742.4K | 2.24M | 3.05M | 7.82M | 6.92M | 3.98M | 6.47M | 4.61M | 1.91M | 3.22M |
| Short-term investments | 0 | 1.00M | 2.00M | 4.00M | 4.00M | 2.00M | 650.0K | |||
| Receivables | 825.3K | 1.34M | 2.84M | 3.41M | 1.28M | 680.0K | 25.2K | 25.2K | 25.2K | 259.3K |
| Inventory | 1 | -259.3K | ||||||||
| Current assets | 1.74M | 3.81M | 7.13M | 13.5M | 12.4M | 4.84M | 7.35M | 7.35M | 2.49M | 3.54M |
| Property, plant and equipment | 0 | 4.30K | 1.67K | 3.66K | 3.92K | 3.60K | 6.38K | 5.63K | 4.34K | 5.87K |
| Total assets | 1.74M | 4.16M | 7.52M | 14.0M | 12.9M | 5.38M | 7.93M | 7.97M | 3.16M | 4.26M |
| Accounts payable | 136.0K | 238.4K | 290.4K | 161.7K | 297.9K | 78.0K | 199.0K | 220.4K | 65.3K | 35.5K |
| Current liabilities | 1.01M | 688.7K | 686.9K | 542.8K | 849.9K | 473.4K | 621.1K | 660.6K | 480.0K | 595.0K |
| Total liabilities | 1.01M | 691.4K | 686.9K | 542.8K | 849.9K | 498.4K | 637.4K | 681.8K | 495.5K | 620.3K |
| Shareholders' equity | 732.9K | 3.47M | 6.84M | 13.4M | 12.0M | 4.88M | 7.30M | 7.29M | 2.66M | 3.64M |
| Shares outstanding | 2.58B | 2.06B | 2.06B | 1.96B | 1.62B | 1.08B | 1.08B | 941.2M | 780.4M | 743.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -1.77M | -1.82M | -5.78M | -8.68M | -3.88M | -2.50M | -129.2K | -2.09M | -1.28M | -1.53M |
| Capital spending | -2 | -3.24K | 0 | -2.29K | -3.89K | -3.89K | -4.06K | -4.13K | -2.77K | -4.90K |
| Free cash flow | -1.77M | -1.82M | -5.78M | -8.68M | -3.88M | -2.50M | -133.2K | -2.09M | -1.28M | -1.54M |
| Cash from investing | 0 | 1.01M | 1.00M | 1.99M | -4.00M | -4.00M | 2.00M | -2.00M | -2.77K | 64.1K |
| Cash from financing | 276.0K | 4.29K | 6.45K | 7.56M | 11.1M | 2.50M | 1.80K | 6.82M | 6.82M | 6.82M |
| Share buybacks | -32.4K | 4.29K | 6.45K | -345.2K | -636.2K | -636.2K | 1.80K | -199.0K | ||
| Change in cash | -1.50M | -804.9K | -4.77M | 901.2K | 2.94M | -2.49M | 1.87M | 2.69M | -1.30M | -1.43M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| Change of Auditor | Nov 11, 2026 | Management or board change | ASX |
| Change in substantial holding | Nov 9, 2026 | Ownership change notice | ASX |
| Change of Director's Interest Notice x2 | Nov 9, 2026 | Ownership change notice | ASX |
| Cleansing Notice | Nov 9, 2026 | Financing | ASX |
| Application for quotation of securities - PAB | Nov 9, 2026 | Financing | ASX |
| Letter to Shareholders - Annual General Meeting | Oct 29, 2026 | Meeting notice | ASX |
| Notice of Annual General Meeting/Proxy Form | Oct 29, 2026 | Meeting notice | ASX |
| Appendix 4C - Quarterly - 30 September 2026 | Oct 28, 2026 | Quarterly report | ASX |
| Appendix 4C - Quarterly - 30 September 2026 | Oct 28, 2026 | Quarterly report | ASX |
| RLS-2202 Phase 1a Trial Advances to Cohort 2 | Oct 21, 2026 | Other filings | ASX |
All 182 filings
Cap table
Built by 6ix from Patrys Limited’s releases · as of Apr 20, 2026
- Common shares
- 340,728,636
- Fully diluted
- 340,728,636
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 340,728,636 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 340,728,636 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Anton Uvarov | Non-Executive Director · Since at least Nov 5, 2026 |
| Brian Leedman | Non-Executive Director · Since at least Nov 5, 2026 |
| Dino Cercarelli | Non-Executive Director · Since at least Nov 5, 2026 |
| Leanne Kite | Non-Executive Director · Since at least Nov 5, 2026 |
| Peter Christie | Non-Executive Chairman · Since at least Nov 5, 2026 |
| Samantha South | Chief Executive Officer · Since at least Oct 5, 2026 |
Log in to ask 6ix AI your own questions about Patrys Limited.